By: Kairos Ventures On: March 28, 2023 In: MemVerge, Portfolio News

MemVerge attends MemCon to demonstrate the capacity and performance benefits of Compute Express Link™ (CXL™) memory. The demo features a...

Read more
By: Kairos Ventures On: March 27, 2023 In: MemVerge, Portfolio News

TechArena host Allyson Klein chats with MemVerge founder and CEO Charles Fan about his company’s disruptive vision for breaking...

Read more
By: Kairos Ventures On: March 24, 2023 In: Kairos News

“The reason they target that time to sell is because [trials] are expensive, but relatively inexpensive [compared to the...

Read more
By: Kairos Ventures On: March 21, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the appointment of Richard Brasel as its Chief Revenue Officer. Brasel brings with him a wealth of...

Read more
By: Kairos Ventures On: February 28, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...

Read more

Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...

Read more
By: Kairos Ventures On: February 13, 2023 In: Kairos News

At the turn of the 21st century, scientists Robert Langreth and Michael Waldholz posited a new idea: What if...

Read more

Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...

Read more
By: Kairos Ventures On: January 19, 2023 In: Linnaeus, Portfolio News

Linnaeus Therapeutics announced that the FDA has granted orphan drug designation for LNS8801 for the treatment of patients with...

Read more
By: Kairos Ventures On: January 18, 2023 In: MemVerge, Portfolio News

MemVerge announced that Jeffrey Wang has been named Vice President of Engineering. With decades of software-defined infrastructure experience across...

Read more